EN
/
FR
Ethics Portal
Who We Are
Who We Are
About Us
Business Model
Our Strategy 2023-2025
Statutes, By-Laws & Policies
Governance & Team
Annual Reports
Careers & RFPs
What We Do
What We Do
Licensing for Public Health
mRNA Technology Transfer Programme
Disease Areas
Addressing Children’s Needs
Prioritising Medicines for Licensing
Long-Acting Therapeutics
Focus areas
Biotherapeutics
Local and Regional Manufacturing
Pandemic Preparedness and Response
Upstream Access
Technology Transfer
Patent Information Tools
MedsPaL
LAPaL
Progress
Progress
Licences
Prioritisation
Agreements with Innovators
Access to Medicines Tracker
Contribution to Universal Health Coverage
Endorsements
Impact
News & Publications
News
& Publications
News, Events & Press Releases
Messages from the Executive Director
MPP in the Media
MPP Publications
Related Publications
Newsletters & Updates
Partners
Partners
Partnering with MPP
Funders
Our Stories
Voices from Friends of MPP
Voices from the Frontline
I am part of the DTG story
How to Give or Get a Licence
Contact Us
EN
/
FR
Ethics Portal
news & publications
»
MPP Publications
MPP Prioritisation Reports – Archives
1 July 2020
2024 Prioritisation Report
2023 Prioritisation Report
2022 Prioritisation Report
2021 Prioritisation Report
2020 Prioritisation Report
2019 Prioritisation Report
2018 Prioritisation Report
Annex to the 2018 Prioritisation Report: HIV and HCV pipelines compiled by the MPP
2017 Prioritisation Report: Prioritisation of HIV and Hepatitis C medicines for in-licensing by the Medicines Patent Pool
2015 Prioritisation Report: Antiretroviral priorities of the Medicines Patent Pool – 4th Edition
2013 Prioritisation Report Priority Antiretrovirals for the Medicines Patent Pool – 3rd Edition (December 2013)
2012 Prioritisation Report
2011 Prioritisation Report
Share page:
Contact Us
Science
Related page
Prioritising Medicines for Licensing